OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
17.33
+0.93 (5.67%)
At close: Aug 13, 2025, 4:00 PM
16.94
-0.39 (-2.25%)
Pre-market: Aug 14, 2025, 9:23 AM EDT
OptimizeRx Employees
As of December 31, 2024, OptimizeRx had 129 total employees, including 128 full-time and 1 part-time employees. The number of employees decreased by 7 or -5.15% compared to the previous year.
Employees
129
Change (1Y)
-7
Growth (1Y)
-5.15%
Revenue / Employee
$812,000
Profits / Employee
-$76,504
Market Cap
321.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
OPRX News
- 5 days ago - OptimizeRx Corporation (OPRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - GlobeNewsWire
- 26 days ago - OptimizeRx: Stock Could Rise As Profitability Is Achieved - Seeking Alpha
- 4 weeks ago - OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - GlobeNewsWire
- 7 weeks ago - OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors - GlobeNewsWire
- 2 months ago - Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire
- 3 months ago - OptimizeRx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript - Seeking Alpha